Anebulo Pharmaceuticals (ANEB) Beats Q2 Earnings Estimates by $0.08
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per…
Read more
